Combination gene therapy for oral cancer in a murine model

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1737-1741

  O'Malley Jr , Bert W ^a   Cope, Keary A ^a   Chen, Shu Hsia ^b   Li, Daqing ^a   Schwartz, Mary R ^b   Woo, Savio L C ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; THYMIDINE KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; GENE THERAPY; HEAD AND NECK CARCINOMA; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS GENE;

ADENOVIRIDAE; ANIMALS; CARCINOMA, SQUAMOUS CELL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; INTERLEUKIN-2; MICE; MICE, INBRED C3H; MOUTH NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE; TIME FACTORS;

EID: 0029870613     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Vokes, E. E , Weichselbaum, R. R , Lippman, S. M., and Hong, W. K. Head and Neck Cancer. N. Engl. J. Med, 328. 184-191, 1993
2. Larson, D. L., Lindberg, R. D., Lane, E., and Goepfert, H. Major complications of radiotherapy in cancer of the oral cavity and oropharynx. Am J Surg , 146: 531-536, 1983.
3. Ervin, T. J., Clark, J. R., Weichselbaum, R. R. Gallon, B. G., Miller, D., Fabian, R L., Posner, M R., Norris, C M , Tuttle, S A , Schoenfeld, D. A., Price, K. N., and Frei, E., III. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J. Clin. Oncol., 5: 10-20, 1987
4. Matthews, T., and Boehme, R Antiviral activity and mechanism of action of ganciclovir Rev. Infect. Dis., 10. s490-s494. 1988.
5. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes paradigm for a prospective cancer control strategy. Cancer Res , 46: 5276-5281, 1986
6. Moolten, F L., and Wells, J M Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors J. Natl Cancer Inst , 82: 297-300, 1990
7. St. Clair, M. H., Lambe, C. U., and Furman, P A. Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Antimicrob Agents Chemother, 31: 844-889, 1987.
8. Freeman, S M , Abboud, C N., Whartenby, K A , Koeplin, D S., Moolten, F L , and Abraham. G. X. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993
9. Wan, L B., Parysek, L M., Warnick, R., and Stambrook, P J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther., 4: 725-731, 1993
10. Fearon, E. R , Pardoll, D. M., Itaya, R . Golumbek, P., Levitsky, H., and Simons, J. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell. 60. 397-403, 1990.
11. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V , Hirofumi, H., Pardoll, D. M., and Mulligan, R C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90: 3539-3543, 1993.
12. Gansbacher, B., Zier, K. Daniels, B., Cronin, K , Bannerji, R., and Gilboa, E Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med., 172; 1217-1224, 1990.
13. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC). 216: 1550-1552, 1992.
14. Oldfield, E H , Ram, Z., Culver, K. W., Blaese, R. M., DeVroom, H. L., and Anderson, W. F Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther., 4: 39-69, 1993.
15. Stratford-Perricaudet, L D , Levrero, M., Chasse, J. F., Perricaudet, M , and Briand, P Hum. Gene Ther., 1: 241-256, 1990.
16. West, W. H., Taver, K W., Yannelli, J. R., Marshall, G. D., Orr, D W., Thurman, G. B., and Oldham, R. K. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J. Med., 316, 898-905, 1987.
17. Chen, S-H., Shine, D., Goodman, J. C., Grossman, R. G., and Woo, S. L. C. Gene therapy for brain tumors' regression of experimental gliomas by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci USA, 91: 3054-3057, 1994
18. O'Malley, B. W., Jr, Chen, S-H., Schwartz, M. R., and Woo, S. L. C Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model Cancer Res , 55: 1080-1085, 1995
19. Fu, K. K , Rayner, P. A., and Lam, K. N. Modification of the effects of continuous low dose radiation by concurrent chemotherapy infusion. Int. Radiat. Oncol Biol. Phys., 10: 1473-1478, 1984.
20. Chen, S-H., Li, Chen, X H., Wang, Y., Kosai, K-I., Finegold, M J., Rich, S. S., and Woo, S. L. C. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci USA, 92 2577-2581, 1995.